Literature DB >> 1806373

Exercise-induced left ventricular dysfunction in coronary heart disease. A model for studying the stunned myocardium in man.

R Scognamiglio1, A Ponchia, G Fasoli, G Miraglia, S Dalla-Volta.   

Abstract

The concept of myocardial stunning encompasses a wide variety of settings with major pathophysiological differences. Stresses, such as exercise-provoked myocardial ischaemia and dysfunction, are accompanied in most patients by a flow-limiting coronary stenosis, while contractile dysfunction persists in some with cessation of exercise. Twenty-six patients with proven coronary artery disease were studied by exercise echocardiography. Left ventricular (LV) volumes, wall motion and myocardial thickening were detected in apical four- and two-chamber views at rest and during upright bicycle exercise. All patients had an increase in total asynergy score and a decrease in ejection fraction (EF) during exercise. Myocardial dysfunction persisted after exercise in 22 patients (84%) as shown by the persistence of low values of LVEF on recovery up to 30 min. When compared to control, nisoldipine reduces total asynergy score and prevents the decline in LVEF during exercise by reducing the extent of myocardial ischaemia. The value of LVEF on recovery is normal. Thus, this particular form of myocardial stunning after exercise-induced ischaemia offers an interesting model for studying (1) the susceptibility of an individual patient and (2) to test the capability of a drug to prevent and to reverse myocardial stunning.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1806373

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  11 in total

1.  Comparison of left ventricular function at rest and post-stress in patients with myocardial infarction: Evaluation with gated SPECT.

Authors:  C D Bavelaar-Croon; Y G America; D E Atsma; P Dibbets-Schneider; A H Zwinderman; M P Stokkel; E K Pauwels; E E van der Wall
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

2.  Pathobiology and Clinical Impact of Reperfusion Injury.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 3.  Myocardial hibernation and stunning: from physiological principles to clinical practice.

Authors:  S R Redwood; R Ferrari; M S Marber
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

4.  Dynamic stress echocardiography for evaluating anti-ischemic drug profiles in post-MI patients.

Authors:  U Nixdorff; R Erbel; S Wagner; T Buck; H Mertes; S Mohr-Kahaly; J Meyer
Journal:  Int J Card Imaging       Date:  1997-12

5.  Prolonged left ventricular dysfunction occurs in patients with coronary artery disease after both dobutamine and exercise induced myocardial ischaemia.

Authors:  E Barnes; C S Baker; D P Dutka; O Rimoldi; C A Rinaldi; P Nihoyannopoulos; P G Camici; R J Hall
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

6.  Pathobiology and Clinical Impact of Reperfusion Injury.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

7.  Stress-related variations in left ventricular function as assessed with gated myocardial perfusion SPECT.

Authors:  Hein J Verberne; Marcel G W Dijkgraaf; G Aernout Somsen; Berthe L F van Eck-Smit
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

Review 8.  Left ventricular dysfunction due to stunning and hibernation in patients.

Authors:  R Ferrari; G La Canna; R Giubbini; E Milan; C Ceconi; F de Giuli; P Berra; O Alfieri; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

Review 9.  Myocardial stunning in man.

Authors:  Edward Barnes; Masood A Khan
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

10.  Transient postischemic stunning evaluation by stress gated Tl-201 SPECT myocardial imaging: Effect on systolic left ventricular function.

Authors:  Sherif I Heiba; Jonas Santiago; Majid Mirzaitehrane; Suman Jana; Fuat Dede; Hussein M Abdel-Dayem
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.